A new skin condition that can be found in many people in Israel and other parts of the Middle East, known as flushing, is also called eczema.
The condition is a form of psoriasis, and it is characterized by a dry, itchy skin rash that can range from mild to severe.
The condition is caused by the abnormal release of the immune system’s natural defences in the skin, causing it to swell, and sometimes to blister.
The rash can become so severe that people lose their ability to walk, move or breathe.
Dr. Yael Geller, the director of the Jerusalem Institute for the Science of Psoriasis (JISPS) told the Maariv newspaper that flushing is a symptom of a genetic disorder called microcephaly.
“A lot of children with this condition, the average age of onset is between 3 and 5 years,” Dr. Geller said.
Microcephalo is a rare disorder, affecting around 1 in 500,000 children worldwide.
The syndrome affects between 0.1 and 1 in 10,000 babies, according to the U.S. Centers for Disease Control and Prevention.
In the United States, microcebaly occurs in around 1,000 to 2,000 infants each year, according a study published in the journal Neurology in 2013.
Microcephalos is most commonly seen in babies born to mothers who are infected with the virus from an infected mother.
It is also a genetic disease that can affect older children.
The disease is treatable, and a number of medications and surgeries can be used to treat it.
The new skin disorder, or flushing or eczemias, can cause the skin to become so dry, irritated or flaky that it can be difficult to remove.
“We have this condition called ecziema, and we know that it’s caused by something that is a mutation in a gene called a SLC25A3 gene,” Dr Geller explained.
The SLC-25A1 gene is the gene that codes for proteins responsible for the production of red blood cells and other blood cells.
Dr. Gellar said that the mutation in the SLC5A4 gene was the culprit in causing eczemsias.
“It has been linked to a condition called microcephalic microcephelon, which is a condition that causes children to have an abnormally small head and limbs and an inability to walk,” Dr Mitzi Geller told the JNF news site.
The disease can be treated with surgery, which can include a facial transplant, an ear or nose transplant, a blood transfusion, and surgery to remove the affected tissue.
However, if the condition becomes too severe, Dr Gellar told the news site, doctors may have to resort to surgery.
“If you have an infection with microcephi, you have a lot of complications and can die, or at least die a painful death,” she said.